 | June 1, 2011
By:William Looney
Now that government payers are turning to pharma to bridge budgetary shortfalls it's best to think long-term
 |
 | June 1, 2011
Meet 2011's Emerging Pharma Leaders—Can these 30 trendsetters build competitive scale from scarcity?
|
 | May 11, 2010
By:William Looney
Pfizer's Specialty Product Business Unit leader discusses his vision for the drug giant's specialty business; now the largest in the industry.
|
 | April 27, 2010
By:Oriana Schwindt
As head of GSK's North American pharma, Deirdre Connelly has the daunting challenge of trying to turn around the sluggish US market. If she succeeds, Connelly may find herself auditioning as the first female Big Pharma CEO.
|
September 30, 2009
By:George Koroneos, Online Content & News Editor
Just months on the job and GSK’s new president of North American Pharmaceuticals Deirdre Connelly is already making her presence known. Her latest move—spearheading an initiative that will boost funding to autonomous CME programs and cut commercial medical education programs. Pharm Exec spoke with Connelly to find out more.
|
September 1, 2009
Brent Saunders, Schering-Plough's president of global consumer healthcare, talks growing role of OTC drugs in Pharma's future.
|
April 1, 2009
"Best Pharma not Big Pharma" is Merck Serono head Elmar Schnee's business philosophy. He tells Pharm Exec Europe how the Swiss-based company aims to achieve that goal, and points out the current political obstacles.
|
March 18, 2009
By:George Koroneos, Online Content & News Editor
Pharm Exec sits down with Kathryn Metcalfe, Pfizer's new vice president of corporate reputation and policy communications to discuss the new position, the perception of pharma among laypeople, and what needs to be done to boost public opinion of the drug industry.
|
February 1, 2009
By:Joanna Breitstein
The world is suffering. But just over the horizon is a new access equation that could speed innovative vaccines to where they're needed most.
|
| 
PharmExec Blog
Follow Us
RSS
Bookstore
